【抗體】《BigHat》旗下「Milliner™」平台將與《Lilly》合作開發下一代抗體
文章出處
Businesswire
原文標題
BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics
Twitter
https://x.com/aimedadviser/status/1914110708859752513
文章序號
7770
智醫科學－AI醫療技術、應用與市場動態
Copyright ©2025 智醫科學 MEDai.tw All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
